Stable Isotope Medical Applications Laboratory, Research Center for Medical Science, Jikei University School of Medicine, Minato-ku, Tokyo 105-8461, Japan.
Radioisotope Research Facilities, Research Center for Medical Science, Jikei University School of Medicine, Minato-ku, Tokyo 105-8461, Japan.
Int J Oncol. 2017 Jun;50(6):2180-2190. doi: 10.3892/ijo.2017.3982. Epub 2017 May 3.
It has been proposed that α-fetoprotein (AFP) is a new member of the intracellular signaling molecule family of the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway via interaction with the phosphatase and tensin homolog (PTEN). In this study, the effects of anti-human AFP antibody on the functions of PTEN were examined using an AFP-producing human hepatoma cell line. The antibody caused significant inhibition of cell growth, compared to a normal IgG control, with the accumulation of intracellular immune complexes followed by significant reduction of cytosolic functional AFP. Decrease in the amount of AKT phosphorylated on serine (S) 473 indicated that PI3K/AKT signaling was suppressed in the cells. S380-phosphorylated PTEN increased markedly by the second day after antibody treatment, with slight but significant increase in the PTEN protein level. Since phosphorylation at S380 is critical for PTEN stability, the increase in S380-phosphorylated PTEN indicated maintenance of the number of PTEN molecules and the related potential to control PI3K/AKT signaling. p53 protein (P53) significantly, but slightly increased during antibody treatment, because PTEN expression increased the stability and function of P53 via both molecular interactions. P53 phosphorylated at S20 or at S392 dramatically increased, suggesting an increase in the stability, accumulation and activation of P53. Glucose transporter 1 (GLUT1) increased immediately after antibody treatment, pointing to a deficiency of glucose in the cells. Immunofluorescence cytology revealed that antibody-treatment re-distributed GLUT1 molecules throughout the cytoplasm with a reduction of their patchy localization on the cell surface. This suggested that translocation of GLUT1 depends on the PI3K/AKT pathway, in particular on PTEN expression. Antibody therapy targeted at AFP-producing tumor cells showed an inhibitory effect on the PI3K/AKT pathway via the liberation, restoration and functional stabilization of PTEN. PTEN simultaneously induced both P53 activation and intracellular translocation of GLUT1, since these are closely associated with PTEN.
有人提出,甲胎蛋白(AFP)通过与磷酸酶和张力蛋白同源物(PTEN)相互作用,成为磷酸肌醇 3-激酶(PI3K)/AKT 信号通路的细胞内信号分子家族的新成员。在这项研究中,使用产生 AFP 的人肝癌细胞系检查了抗人 AFP 抗体对 PTEN 功能的影响。与正常 IgG 对照相比,该抗体导致细胞生长显著抑制,细胞内免疫复合物积累,随后细胞溶质功能性 AFP 显著减少。AKT 丝氨酸(S)473 磷酸化减少表明细胞中 PI3K/AKT 信号被抑制。抗体处理后第二天 S380 磷酸化的 PTEN 明显增加,PTEN 蛋白水平略有但显著增加。由于 S380 磷酸化对 PTEN 稳定性至关重要,因此 S380 磷酸化的 PTEN 增加表明维持了 PTEN 分子的数量和控制 PI3K/AKT 信号的相关潜力。抗体处理过程中 p53 蛋白(P53)显著但略有增加,因为 PTEN 表达通过分子相互作用增加了 P53 的稳定性和功能。P53 在 S20 或 S392 处磷酸化急剧增加,表明 P53 的稳定性、积累和激活增加。抗体处理后葡萄糖转运蛋白 1(GLUT1)立即增加,表明细胞内葡萄糖缺乏。免疫荧光细胞术显示,抗体处理将 GLUT1 分子重新分布到细胞质中,减少了其在细胞表面的块状定位。这表明 GLUT1 的易位取决于 PI3K/AKT 途径,特别是依赖于 PTEN 表达。针对产生 AFP 的肿瘤细胞的抗体治疗通过释放、恢复和功能稳定 PTEN,对 PI3K/AKT 途径显示出抑制作用。PTEN 同时诱导 P53 激活和 GLUT1 的细胞内易位,因为这些与 PTEN 密切相关。